Co-Formulation of Pembrolizumab Murine Surrogate RMP1-14 with Imagent ® Ultrasound Contrast Agent Enhances Intratumoral Antibody Delivery Through a Transient Increase in Tumor Blood Perfusion.

Saved in:
Bibliographic Details
Title: Co-Formulation of Pembrolizumab Murine Surrogate RMP1-14 with Imagent ® Ultrasound Contrast Agent Enhances Intratumoral Antibody Delivery Through a Transient Increase in Tumor Blood Perfusion.
Authors: Kirven, Imani A.1 (AUTHOR), Penfornis, Patrice1,2 (AUTHOR), Siddiqui, Muhammad R.2,3 (AUTHOR), Butler, Kenneth R.1,4 (AUTHOR), Roman, Richard J.1 (AUTHOR), Larsen, Clayton T.2,3 (AUTHOR), Howard, Candace M.3,4 (AUTHOR), Claudio, Pier Paolo1,4 (AUTHOR) pclaudio@umc.edu
Source: Pharmaceutics. Jun2026, Vol. 18 Issue 6, p690. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 194907843
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Co-Formulation of Pembrolizumab Murine Surrogate RMP1-14 with Imagent ® Ultrasound Contrast Agent Enhances Intratumoral Antibody Delivery Through a Transient Increase in Tumor Blood Perfusion.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Kirven%2C+Imani+A%2E%22">Kirven, Imani A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Penfornis%2C+Patrice%22">Penfornis, Patrice</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Siddiqui%2C+Muhammad+R%2E%22">Siddiqui, Muhammad R.</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Butler%2C+Kenneth+R%2E%22">Butler, Kenneth R.</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Roman%2C+Richard+J%2E%22">Roman, Richard J.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Larsen%2C+Clayton+T%2E%22">Larsen, Clayton T.</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Howard%2C+Candace+M%2E%22">Howard, Candace M.</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Claudio%2C+Pier+Paolo%22">Claudio, Pier Paolo</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<i> pclaudio@umc.edu</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Pharmaceutics%22">Pharmaceutics</searchLink>. Jun2026, Vol. 18 Issue 6, p690. 17p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=194907843
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/pharmaceutics18060690
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 17
        StartPage: 690
    Titles:
      – TitleFull: Co-Formulation of Pembrolizumab Murine Surrogate RMP1-14 with Imagent ® Ultrasound Contrast Agent Enhances Intratumoral Antibody Delivery Through a Transient Increase in Tumor Blood Perfusion.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kirven, Imani A.
      – PersonEntity:
          Name:
            NameFull: Penfornis, Patrice
      – PersonEntity:
          Name:
            NameFull: Siddiqui, Muhammad R.
      – PersonEntity:
          Name:
            NameFull: Butler, Kenneth R.
      – PersonEntity:
          Name:
            NameFull: Roman, Richard J.
      – PersonEntity:
          Name:
            NameFull: Larsen, Clayton T.
      – PersonEntity:
          Name:
            NameFull: Howard, Candace M.
      – PersonEntity:
          Name:
            NameFull: Claudio, Pier Paolo
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: Jun2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 19994923
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Pharmaceutics
              Type: main
ResultId 1